- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04938310
Impact of Wearing a Support Garment Following Parietal Gastrectomy
August 4, 2025 updated by: Laurent Biertho, Laval University
Impact of Wearing a Support Garment on Mobility, Functional Capacity, Self-esteem, Quality of Life and Skin Maceration Following Parietal Gastrectomy
Custom-made orthopedic support equipment and abdominal-lumbar support belts offer promising potential for several aspects affecting the health and well-being of people with obesity who choose a surgical weight loss option.
However, research is needed to quantitatively document their short and long term effects on a wide range of parameters related to mobility, quality of life, lower back pain and skin maceration following parietal gastrectomy.
The objective of this study is to characterize the effect of a support garment in an experimental design where a subgroup of participants will be randomized and followed for the first 12 months after a gastrectomy.
The measures will be: physical activity, lower back pain, self-esteem, quality of life, skin maceration and infections.
This study will scientifically document the usefulness and effectiveness of support garments throughout the weight loss surgery process.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
6
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Quebec City, Quebec, Canada, G1V 4G5
- Criucpq-Ul
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- meeting the NIH criteria for bariatric surgery
- BMI >= 35 kg/m2
Exclusion Criteria:
- chronic pulmonary obstructive disease
- gastric stoma
- psychiatric disease contraindicated for bariatric surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group
Sleeve gastrectomy
|
sleeve gastrectomy
|
|
Experimental: Support garment group
Sleeve gastrectomy followed by a period of 12-month with a support garment
|
sleeve gastrectomy
A custom made support garment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Excess skin
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Excess skin measured with the Iglesias scale, scores are from 1 to 5, higher score means a worse excess skin
|
From baseline to 12 month following sleeve gastrectomy
|
|
Skin maceration
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
maceration evaluated with an in-house questionnaire reported as presence or absence of skin maceration
|
From baseline to 12 month following sleeve gastrectomy
|
|
Skin infection
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
infection evaluated with an in-house questionnaire reported as presence or absence of skin infection
|
From baseline to 12 month following sleeve gastrectomy
|
|
Impact of excess skin
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Sahlgrenska Excess Skin questionnaire assesses excess skin after weight loss for specific body parts and body as a hole.
Inconvenience of excess skin is evaluated on a scale from 0 to 10, higher score means higher perception that the excess skin is an inconvenience.
|
From baseline to 12 month following sleeve gastrectomy
|
|
Physical activity
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Physical activity evaluated by wearing an activity monitor
|
From baseline to 12 month following sleeve gastrectomy
|
|
Physical activity
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Global Physical Activity Questionnaire
|
From baseline to 12 month following sleeve gastrectomy
|
|
Lower back pain
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Quebec back pain scale, scores are from 0 to 100, higher score means greater difficulty in carrying out activities due to low back pain
|
From baseline to 12 month following sleeve gastrectomy
|
|
Self esteem
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Rosenberg self esteem scale, scores are from 10 to 40, higher score mean a stronger self esteem
|
From baseline to 12 month following sleeve gastrectomy
|
|
Self esteem related to physical appearance
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Body Esteem Scale for Adolescent and Adults contains 3 subscales for weight, appearance and attribution.
Scores are from 1 to 5, higher score means higher self esteem.
|
From baseline to 12 month following sleeve gastrectomy
|
|
Body image
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Gender-specific body-size guide is a pictorial method of assessing the perception of weight status.
It consists of 10 standardized images of adults with known BMI values and is a validated body size perception tool.
The scale is gender specific and images range from underweight (BMI <18.5) to class III obesity (BMI> = 40) with approximately a 3 point difference in BMI between the figures on the scale.
|
From baseline to 12 month following sleeve gastrectomy
|
|
Body image
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
body shape questionnaire, scores are from 34 to 204, higher score means worse feeling about the appearance.
|
From baseline to 12 month following sleeve gastrectomy
|
|
Body image
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Eating Disorders Examination Questionnaire contains subscales for restraint, eating concern, shape concern and weight concern.
Each subscales and global scale scores are form 0 to 6, higher score means worse outcome
|
From baseline to 12 month following sleeve gastrectomy
|
|
Severity of depression symptoms
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Beck Depression Inventory II questionnaire, scores are from 0 to 63, higher score means more severe depressive symptoms.
|
From baseline to 12 month following sleeve gastrectomy
|
|
Anxiety
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
State-Trait Anxiety Inventory contains 2 subscales for usual emotional state and current emotional state.
Scores are from 20 to 80, higher scores means higher anxiety state.
|
From baseline to 12 month following sleeve gastrectomy
|
|
Social Physique Anxiety
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Social Physique Anxiety Scale, scores are from 12 to 60, higher score means more anxiety
|
From baseline to 12 month following sleeve gastrectomy
|
|
Quality of life
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Laval questionnaire contains 6 subscales for symptoms, activity/mobility, personal hygiene/clothing, emotions, social interactions, and sex life.
scores are from 1 to 7, higher score means higher quality of life in each domain
|
From baseline to 12 month following sleeve gastrectomy
|
|
marital satisfaction
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Dyadic adjustment scale, scores are from 0 to 151, higher score indicates a higher level of marital functioning
|
From baseline to 12 month following sleeve gastrectomy
|
|
social ideals of physical appearance
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
Sociocultural Attitude Towards Appearance Questionnaire-4 contains 6 subscales (internalization: thinness / low fat mass, internalization: muscular, internalization: general attractiveness, pressures: family, pressures: media, pressures: similar and other significant).
Scores are from 1 to 5, higher scores indicating greater internalization and endorsement of societal appearance ideals
|
From baseline to 12 month following sleeve gastrectomy
|
|
gastroesophageal reflux disease
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
GastroEsophageal Reflux Disease Score, scores are from 0 to 96, higher score indicates worse gastroesophageal reflux symptoms
|
From baseline to 12 month following sleeve gastrectomy
|
|
adherence in wearing the support garment
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
adherence in wearing the support garment evaluated with an adherence journal.
Adherence will be calculated as a percentage from the total number of days the participant wears the garment out of the total for the intervention.
|
From baseline to 12 month following sleeve gastrectomy
|
|
persistence in wearing the support garment
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
persistence in wearing the support garment will be calculated as a percentage by reporting the number of participants who have stopped wearing the garment compared to those who have used it.
|
From baseline to 12 month following sleeve gastrectomy
|
|
Body composition
Time Frame: From baseline to 12 month following sleeve gastrectomy
|
body fat composition assessed by impedance
|
From baseline to 12 month following sleeve gastrectomy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 4, 2021
Primary Completion (Actual)
December 1, 2021
Study Completion (Actual)
December 1, 2021
Study Registration Dates
First Submitted
May 28, 2021
First Submitted That Met QC Criteria
June 16, 2021
First Posted (Actual)
June 24, 2021
Study Record Updates
Last Update Posted (Actual)
August 8, 2025
Last Update Submitted That Met QC Criteria
August 4, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Bodynov
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on sleeve gastrectomy
-
Hartford HospitalNational Institutes of Health (NIH)Active, not recruiting
-
King Saud UniversityNew You Medical CenterCompletedBariatric Surgery Candidate | Obesity, Childhood | Cardiovascular Risk FactorSaudi Arabia
-
Centre Hospitalier Departemental VendeeRecruiting
-
Mina Kamal Gergis ErianKasr El Aini HospitalActive, not recruitingMetabolic Diseases | Quality of Life | Obesity | Nutritional Status | Morbid Obesity | Bariatric Surgery | Dumping Syndrome | Sleeve Gastrectomy | Postgastrectomy Syndrome | Patient-reported Outcome Measures | Gastrointestinal Function Disorders | Gastrointestinal TransitEgypt
-
Helse FordeRecruitingGastroesophageal RefluxNorway
-
King Saud UniversityNew You Medical CenterCompleted
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Ricard CorcellesRecruitingQuality of Life | Obesity | Bariatric Surgery Candidate | Post Operative Pain | Laparoscopic Sleeve Gastrectomy | Robotic Sleeve GastrectomyUnited States
-
Sengkang General HospitalSingapore General HospitalRecruitingObesity | Gastroesophageal Reflux | Bariatric Surgery Candidate | Esophagus InjurySingapore